Economic Cost of Acute Coronary Syndrome in Australia
A new series of Heart Foundation reports reveal the total economic cost of acute coronary syndrome (ACS), which includes heart attack and unstable angina, is $6.8 billion in 2017-18. The largest share of this figure is the loss of income for individuals who experience an ACS event, estimated at $3.5 billion. This is followed by the $1.9 billion on healthcare expenditure associated with ACS events, such as hospital stays.
The Medical Research Future Fund
The Heart Foundation has made a submission to the Medical Research Future Fund (MRFF) Priorities for 2018-2020. We are advocating to ensure that greater priority is given to cardiovascular disease research.
We believe that MRFF research allocations should reflect the burden of disease and target gaps in knowledge and capacity including preventive health, chronic disease, primary care, clinical research fellowships, rheumatic heart disease prevention, better translational research, greater clinical trial capacity and improved prediction of risks.
Federal Budget submission 2018-19
This pre-Budget submission advances a suite of good, practical policy proposals that plug significant gaps in the nation’s current approach to preventing, treating and managing a leading killer of Australians – cardiovascular disease.
Cardiovascular disease (CVD) comprises a number of individual diseases, including coronary heart disease, stroke, heart failure, arrhythmias, congenital conditions, hypertensive disease and peripheral vascular disease.
World No Tobacco Day 2018
Tobacco smoke is one of the main risk factors for heart disease and is responsible for 12% of the burden of cardiovascular disease in Australia.